Fig. 11
From: Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1
Schematic summary of the bidirectional interactions between tacrolimus (TAC) and the gut microbiota. After oral administration, TAC diffuses passively in the small intestine but the efflux transporter ABCB1A (encoded by Abcb1a in mice) limits its absorption. Some of the drug reaches the blood circulation and is then metabolized in the liver by CYP3A enzymes (encoded by Cyp3a11 and Cyp3a13 in mice). In the lumen, the gut microbiota produces compounds/metabolites. Some of them have a repressive effect on Abcb1a expression (red arrow), resulting in less efflux activity. Moreover, TAC impacts the gut microbiota composition (blue arrow). Created with BioRender.com